Intestinal mucormycosis initially identified by next-generation sequencing of cell-free DNA
- PMID: 34176206
- DOI: 10.1111/tid.13656
Intestinal mucormycosis initially identified by next-generation sequencing of cell-free DNA
Abstract
Mucormycosis is a rare fungal infection that typically affects severely immunocompromised individuals, often resulting in significant morbidity and mortality. Although early and aggressive intervention is necessary to prevent poor outcomes, diagnosis of this infection remains difficult. We report the first case, to our knowledge, of invasive gastrointestinal mucormycosis initially identified by next-generation sequencing of cfDNA from the blood, and discuss the various benefits and challenges which come with new molecular diagnostic techniques.
Keywords: cell-free DNA; invasive fungal infection; mucormycosis; next-generation sequencing; transplant.
© 2021 Wiley Periodicals LLC.
References
REFERENCES
-
- Lanternier F, Sun H-Y, Ribaud P, Singh N, Kontoyiannis DP, Lortholary O. Mucormycosis in organ and stem cell transplant recipients. Clin Infect Dis. 2012;54(11):1-8. https://doi.org/10.1093/cid/cis195
-
- Skiada A, Lass-Floerl C, Klimko N, Ibrahim A, Roilides E, Petrikkos G. Challenges in the diagnosis and treatment of mucormycosis. Med Mycol. 2018;56(suppl_1):S93-S101. https://doi.org/10.1093/mmy/myx101
-
- Karius Inc. Karius Test. https://www.kariusdx.com/products/karius-test. Published 2019. Accessed August 13, 2019.
-
- Blauwkamp TA, Thair S, Rosen MJ, et al. Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease. Nat Microbiol. 2019;4(4):663-674. https://doi.org/10.1038/s41564-018-0349-6
-
- U.S. Centers for Disease Control and Prevention (CDC). Mucormycosis Statistics|Mucormycosis|Fungal Diseases|CDC. https://www.cdc.gov/fungal/diseases/mucormycosis/statistics.html. Published 2019. Accessed August 19, 2019.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
